Tag: Alzheimer’s

Large Study Found Flu and Common Virus Linked to Neurological Disease, but They May Not Be the Cause: Experts

Someone is diagnosed with the condition every four seconds. New research finds common virus infections are linked to developing a degenerative brain disease. But experts also have different opinions. Common Virus Infections Associated with Neurological Disease Risk: Study “We are seeing mounting evidence,” Heather Snyder, Alzheimer’s Association vice president of medical and scientific relations and who holds a…


New Alzheimer’s Treatment Would Cost $26,500 Per Year

A new Alzheimer’s treatment would cost patients an estimated $26,500 per year, said the drug developer. The Food and Drug Administration (FDA) announced on Jan. 6 that it would grant accelerated approval to Biogen and Eisai, after the drug appeared to partially slow the development of mild cases of Alzheimer’s disease in clinical trials. The same day, Eisai submitted…


FDA Grants Accelerated Approval for Alzheimer’s Drug Lecanemab

The U.S. Food and Drug Administration (FDA) on Friday granted accelerated approval for the experimental dementia drug lecanemab. Lecanemab, which will be marketed as Leqembi, is the second of a new class of Alzheimer’s disease drugs that target the illness’s core pathophysiology, according to the FDA, which said the drug is a significant step forward…


FDA’s Approval Process of Controversial Alzheimer’s Drug Was ‘Rife With Irregularities’: Congressional Probe

The U.S. Food and Drug Administration’s (FDA) approval process of the controversial and costly new Alzheimer’s drug Aduhelm was “rife with irregularities” and “highly atypical,” according to a report released on Dec. 29 by the House Oversight and Energy and Commerce committees. The report (pdf) is the result of an 18-month investigation conducted by the Committee on Oversight and Reform, and Committee…


Lecanemab: A New Potential Drug for Alzheimer’s Disease 

The treatment of Alzheimer’s disease has been a long-standing challenge and area of interest. The knowledge in pathogenesis and an increased disease burden have prompted innovative therapeutics over the last two decades. There are six drugs approved by Food and Drug Administration (FDA) for the treatment, but there is no cure for Alzheimer’s disease despite all…


Nose Picking May Increase Risk of Dementia

Nose-picking is a very common behavior. However, studies show that when people pick their noses, they may also allow a type of bacteria to invade their brain, increasing the risk of Alzheimer’s disease. Can Nose Picking Increase the Risk of Dementia? A study by Griffith University in Australia found that Chlamydia pneumoniae can invade the brain…


13 Alzheimer’s Disease Misconceptions—and the Truth Behind Them

Medically reviewed by Dr. Ari Magill First described by Alois Alzheimer in 1906, Alzheimer’s disease (AD) is a progressive neurologic disorder that disrupts memory and thinking. Despite understanding a lot about its symptoms, two big questions remain: What causes Alzheimer’s? When will there be a definitive cure for AD? Unfortunately, we don’t have one cause…


Music: Bridging Memories for People With Alzheimer’s

Wes Mika started out on drums, but in his heart, he was a tambourine man. “He got fascinated by the little silver discs on the tambourine,” said his wife, Susan Mika. “Sometimes he would hit the tambourine with the little mallets of the drum. He just loved that tambourine.” Wes, 77, has dementia and lives…


These 2 Personality Traits, Toxic to the Brain, Give You Higher Risk for Alzheimer’s

Science has not yet arrived at a complete understanding of the causes of Alzheimer’s disease. However, recent findings have confirmed the association between personality and neuropathology, in that certain personality traits can increase Alzheimer’s risk. The results of the study conducted by Terracciano et al. show that individuals with higher neuroticism and lower conscientiousness have…


Cancer, Dementia Deaths Up in Australia Following Pandemic Years

Australia in 2022 has so far seen an increase in deaths from cancer, dementia, and diabetes. The findings from the Australian Bureau of Statistics (ABS) come after elective surgeries were suspended during the pandemic years over concerns hospitals could not cope with the volume of extra patients. The ABS found 75,593 deaths occurred since the start…